Bottles of pills arranged in shelf at a drugstore

Medicine’s Paul Tesar discusses the advancement of PMD treatment

CWRU grants exclusive license to Ionis Pharmaceuticals to advance therapy for rare childhood disorder

Photo of Paul Tesar
Paul Tesar

Crain’s Cleveland Business(subscription required): Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics at the School of Medicine, discussed a new exclusive license agreement with Ionis Pharmaceuticals Inc. to advance and commercialize a therapeutic approach that university medical researchers discovered to treat a rare childhood degenerative disorder called Pelizaeus-Merzbacher disease (PMD).